642 Letters in Organic Chemistry, 2011, Vol. 8, No. 9
Chepyala et al.
this cyclization reaction, that results in compounds 23 and
24. Compound 23 was treated with aq. HCl or NaOH in
ethanol at reflux resulted in mono-acid 25 in 44% isolated
yield and rest was starting material, and it was observed that
this was not converting in to di acid. The increase in the
basicity or temperature of the reaction is leading to
decomposition. Where as compound 24 was hydrolyzed
using aq. sodium hydroxide solution in the presence of THF
gave a di acid Compound 26 (Scheme 4) charecterized by
1H-NMR and Mass. Compound 23 was treated with amines
like piperazine in NMP at 800C resulted in Compound 27.
Compound 27 was treated with aq. NaOH in methanol at
reflux resulted in Compound 28.
Compounds (15-17 and 28) were insoluble in test
solution, hence activity test was not performed and
interestingly Compounds 20 and 26 do not show any activity
towards Gram negative and do show activity over Gram
positive. Compounds 18, 25, 29-33 do show activity towards
Gram negative and do not show activity over Gram positive.
Compounds 23, 24 and 27 were shown zero activity for both
the strains. All other compounds (19, 34-37) were shown
approximately half of the activity when compared with
standard (Ciprofloxacin).
CONCLUSION
1,4-dihydro-4-oxo-7-substituted
amino-6-fluoroquino-
line-3-carboxylic acids and its ester derivatives are effective
against a variety of gram negative microorganisms. Since
fluoro quinolinones are important and high demand
antibacterial agents, here we have explored the synthesis of
N1-quinolone dimer analogues. Keeping a substitution at
N1-position having a STERIMOL length of 0.42 nm with a
2-carbon chain linker as an important parameter, we have
used linkers such as 1, 2-diaminoethane and 1, 2-
diaminocyclohexane, to satisfy steric, special and electronic
interactions. 1, 2 diamino cyclohexane, was used to restrict
the free rotation across the linker to understand the
bioavailability as well as activity. The in-vitro antibacterial
activity result shows that these dimers are having moderate
activity when compared with Ciprofloxacin.
Antibacterial Activity
The in vitro antibacterial activity of the compounds were
tested in comparison with ciprofloxacin and determined by
conventional agar dilution procedure. Dimethylsulfoxide
(DMSO) was used to control negative. Here responses (Zone
of inhibition) of microorganisms to the synthesized
compounds were measured in mm and are compared with
the standard reference drug (i.e. Ciprofloxacin). The two
microorganisms used were Escherichia coli ATCC 8739
(Gram negative) and Staphylococcus aureus ATCC 6538
(Gram positive).
Table 2. In vitro Antibacterial Activity Fluoro Quinolone N1-
Dimers (18-20, 23-27, 30-37) Tested for Gram
Negative and for Gram Positive in DMSO (50 μg/100
μL) and the “Zone of Inhibition” Values are
Measured in mm. Ciprofloxacin was Used as a
Standard
ACKNOWLEDGEMENTS
We thank Dr. Satyanarayana C. and Dr. Mani Bushan K.
for their support.
Zone of inhibition in mm
Compound No
Escherichia coli
Staphylococcus aureus
SUPPLEMENTARY MATERIAL
18
14
16
0
0
10
12
0
Supplementary material is available on the publishers
Web site along with the published article.
19
20
23
0
REFERENCES
24
0
0
[1]
Koga, H.; Itoh, A.; Murayama, T.; Suzue, S.; Irikura, T. Structure-
activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-
alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids. J. Med.
Chem., 1980, 23, 1358-1363. Wise, R.; Andrews, J.; Edward, L. In
vitro activity of Bay 09867, a new quinoline derivative, compared
with those of other antimicrobial agents. Antimicrob. Agents
chemother., 23, 1983, 559-564.
Matsumoto, J.; Miyamoto, T.; Minamida, A.; Nishamura, Y.;
Egawa, H.; Nishamura, H. 1,4-Dihydro-4-oxopyridinecarboxylic
acids as antibacterial agents. 2. Synthesis and structure-activity
relationships of 1,6, 7-trisubstituted 1,4-dihydro-4-oxo-1,8-
25
12
0
0
26
12
0
27
0
29
12
15
15
15
15
16
20
19
22
36
0
[2]
[3]
30
0
31
0
naphthyridine-3-carboxylic acids, including enoxacin,
a new
32
0
antibacterial agent. J. Med. Chem., 1984, 27, 292-301.
Chu, D. T. W.; Fernandes, P. B.; Claiborne, A. K.; Pihuleac, E.;
Nordeen, C. W.; Maleczka, R. E.; Pernet, A. Synthesis and
structure activity relationship of 1-Aryl-6,8-difluoroquinolone
Antibacterial agents. J. Med. Chem., 1987, 30, 504-509. Schentage,
J.; Domagala, J. Structure-activity relationship with the quinolone
anti biotics. Res. Clin. Forums., 1985, 7, 9-13. Chu, D. T. W.;
Maleczka, R. E. Synthesis of 4-Oxo-4H-quino[2,3,4-
I,j][1,4]benoxazine-5-carboxylic acid derivatives. J. Hetrocyclic
Chem., 1987, 24, 453-456. David J. A.; Andrew, H. F.; Edward F.
K. Synthesis and antibacterial Activity of 2,3-Dehydrooflaxacin. J.
Hetrocyclic Chem., 1990, 27, 1509-1511.
33
0
34
12
14
14
15
38
35
36
37
Ciprofloxacin